Edition:
United Kingdom

People: Editas Medicine Inc (EDIT.OQ)

EDIT.OQ on NASDAQ Stock Exchange Global Select Market

25.59USD
9:00pm BST
Change (% chg)

$-0.19 (-0.74%)
Prev Close
$25.78
Open
$25.73
Day's High
$26.11
Day's Low
$25.37
Volume
141,240
Avg. Vol
233,486
52-wk High
$33.79
52-wk Low
$17.90

Albright, Charles 

Dr. Charles Albright Ph.D., is a Chief Scientific Officer of the EDITAS MEDICINE, INC. since August 2016. Prior to joining our company, Dr. Albright served in a variety of roles at Bristol-Myers Squibb Company, a biopharmaceutical company, from January 2004 to August 2016, serving most recently as the Vice President, Genetically Defined Diseases and Genomics. Dr. Albright received his B.S. in chemical engineering and a Ph.D. in biology from the Massachusetts Institute of Technology..

Basic Compensation

Total Annual Compensation, USD 523,477
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,864,420
Fiscal Year Total, USD 2,387,900

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 20,000 379,579.00
Name Fiscal Year Total

James Mullen

612,362

Cynthia Collins

479,814

Eric Ek

--

Vickesh Myer

2,455,740

Charles Albright

2,387,900

Katrine Bosley

7,989,380
As Of  31 Dec 2018